Gary Gillheeney
Chief Executive Officer bei ORGANOGENESIS HOLDINGS INC.
Vermögen: 7 Mio $ am 31.03.2024
Profil
Gary S.
Gillheeney is currently the Chairman, President & Chief Executive Officer at Organogenesis, Inc. He is also the Chairman, President & Chief Executive Officer at Organogenesis Holdings, Inc. and the Director at Massachusetts Biotechnology Council.
Previously, he served as the CFO, Treasurer, Senior VP & Assistant Secretary at Providence Energy Corp.
and as the CFO, COO, Secretary & Treasurer at Innovative Clinical Solutions Ltd.
He obtained his undergraduate degree from American International College and his MBA from Bryant University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.04.2024 | 2 351 949 ( 1,78% ) | 7 Mio $ | 31.03.2024 |
Aktive Positionen von Gary Gillheeney
Unternehmen | Position | Beginn |
---|---|---|
ORGANOGENESIS HOLDINGS INC. | Chief Executive Officer | 01.01.2014 |
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Chief Executive Officer | 01.01.2014 |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Director/Board Member | 14.05.2018 |
Ehemalige bekannte Positionen von Gary Gillheeney
Unternehmen | Position | Ende |
---|---|---|
Innovative Clinical Solutions Ltd.
Innovative Clinical Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Innovative Clinical Solutions, Ltd. operated two business lines: investigative clinical site management including outcomes research, and single-specialty provider network management. The Company was founded in 1994 and was headquartered in Providence, RI. | Director of Finance/CFO | 01.01.2002 |
Providence Energy Corp. | Director of Finance/CFO | - |
Ausbildung von Gary Gillheeney
American International College | Undergraduate Degree |
Bryant University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ORGANOGENESIS HOLDINGS INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
Providence Energy Corp. | Utilities |
Innovative Clinical Solutions Ltd.
Innovative Clinical Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Innovative Clinical Solutions, Ltd. operated two business lines: investigative clinical site management including outcomes research, and single-specialty provider network management. The Company was founded in 1994 and was headquartered in Providence, RI. | Commercial Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |